DGAP-News

Fresenius Medical Care AG & Co. KGaA: reports strong operating figures and confirms guidance for full year 2014

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Half
Year Results
Fresenius Medical Care AG & Co. KGaA: reports strong operating figures
and confirms guidance for full year 2014

31.07.2014 / 07:22

---------------------------------------------------------------------

July 31, 2014

INVESTOR NEWS

Fresenius Medical Care reports strong operating results for the second
quarter 2014 and confirms guidance for full year 2014


- Second quarter shows accelerated growth

- Improvement of underlying operating performance driven by both the
North American as well as International segment

- Implemented further initiatives in the second quarter to expand the
care coordination activities

- Company remains on track to achieve full year guidance

Second quarter 2014 key figures:
Net revenue $3,835 million +6%
Operating income (EBIT) $556 million +2%
Net income1 $234 million -11%
Net income adjusted2 $252 million -4%
Basic earnings per share $0.77 -10%
Adjusted earnings per share2) $0.83 -3%

First half 2014 key figures:
Net revenue $7,398 million +5%
Operating income (EBIT) $1,001 million -4%
Net income1 $439 million -10%
Net income adjusted2 $457 million -6%
Basic earnings per share $1.46 -9%
Adjusted earnings per share2 $1.52 -5%

Rice Powell, chief executive officer of Fresenius Medical Care stated: "The
second quarter showed sequentially enhanced revenue growth and improved
strong operating performance. We expect the organic growth to continue in
the second half of the year and are confident to meet our guidance for the
full year as well as our cost savings target of up to $60 million before
tax for 2014. With our recent acquisitions of Sound Physicians and
MedSpring Urgent Care we made important steps in our strategy of expanding
our service network to achieve excellent patient care in a more coordinated
and integrated model."

________________________________
1)attributable to shareholders of Fresenius Medical Care AG & Co. KGaA
2) adjusted for an unfavorable tax impact of USD 18 million in the second
quarter of 2014

Second quarter 2014

Revenue

Net revenue for the second quarter of 2014 increased by 6% to $3,835
million (+7% at constant currency) compared to the second quarter of 2013.
Organic revenue growth worldwide was 5%. Dialysis services revenue grew by
7% to $2,949 million (+8% at constant currency) and dialysis product
revenue increased by 2% to $886 million (+1% at constant currency) compared
to the second quarter of 2013.